|
|
|
|
Document Preview Additional Investment Right |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Additional Investment Right |
|||
|
Entities: |
Hemispherx BioPharma, Inc.; Interferon Sciences, Inc.; Schulte Roth & Zabel LLP |
|||
|
Date: |
2004 |
|||
|
Size: |
Preview shows 5KB of 227KB total |
|||
|
Price: |
$73 |
|||
|
ID: |
#305118 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF
1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS OR (B) AN OPINION OF
COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED
BY THE SECURITIES.
HEMISPHERX BIOPHARMA, INC.
ADDITIONAL INVESTMENT RIGHT
Additional Investment Right No. [ ] Dated: _____________, 2004
Hemispherx Biopharma, Inc., a Delaware corporation (the "Company"), hereby
certifies that, for value received, [Name of Holder] or its registered assigns
(the "Holder"), is entitled to purchase from the Company up to a total of
$2,000,000 in principal amount of 6% senior secured convertible debentures due
January 31, 2006 of the Company in the form attached as Exhibit A hereto (each
such debenture, an "Additional Debenture" and all such debentures, the
"Additional Debentures"), at any time or from time to time from and after July
26, 2004 (the "Trigger Date") and through and including the later of (i) 90 days
following the date on which the Registration Statement is declared effective and
(ii) 90 days following the Trigger Date (the "Expiration Date"), and subject to
the following terms and conditions. This Additional Investment Right (this
"Additional Investment Right") is one of a series of similar additional
investment rights issued pursuant to that certain Securities Purchase Agreement,
dated as of the date hereof, by and among the Company and the Purchasers
identified therein (the "Securities Purchase Agreement"). All such additional
investment rights are referred to herein, collectively, as the "Additional
Investment Rights."
1. Definitions. In addition to the terms defined elsewhere in this
Additional Investment Right, capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Securities Purchase
Agreement.
2. Registration of Additional Investment Right. The Company shall register
this Additional Investment Right, upon records to be maintained by the Company
for that purpose (the "Additional Investment Right Register"), in the name of
the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Additional Investment Right as the absolute owner
hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.
{PAGE}
3. Registration of Transfers. The Company shall register the assignment
and transfer of any portion of this Additional Investment Right in the
Additional Investment Right Register, upon surrender of this Additional
Investment Right, with the Form of Assignment attached hereto duly completed and
signed, to the Company at its address specified herein. Upon any such
registration or transfer, a new additional investment right to purchase
Additional Debentures, in substantially the form of this Additional Investment
Right (any such new additional investment right, a "New Additional Investment
Right"), evidencing the portion of this Additional Investment Right so
transferred shall be issued to the transferee and a New Additional Investment
Right evidencing the remaining portion of this Additional Investment Right not
so transferred, if any, shall be issued to the transferring Holder. The
acceptance of the New Additional Investment Right by the transferee thereof
shall be deemed the acceptance by such transferee of all of the rights and
obligations of a holder of an Additional Investment Right.
4. Exercise and Duration of Additional Investment Right.
(a) This Additional Investment Right shall be exercisable by the
registered Holder at any time or from time to time on or after the Trigger Date
to and including the Expiration Date; provided, however, that the Expiration
Date shall be extended for each day after the Effectiveness Deadline (as defined
in the Registration Rights Agreement) that the Registration Statement is not
effective. At 6:30 P.M., New York City time on the Expiration Date, the portion
of this Additional Investment Right not exercised prior thereto shall be void
and of no further force and effect. Notwithstanding anything herein to the
contrary, following the Trigger Date, the Company shall have the right, in its
sole discretion, to accelerate the Expiration Date (the "Company's Acceleration
|
End of Preview |
Home Intelligence Services Subscriptions News About Us